Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing
28/11/2025 22:28
Nov 28 (Reuters) - Actuate Therapeutics Inc ACTU.O: ACTUATE THERAPEUTICS INC - MAY SELL COMMON STOCK UP TO $100 MILLION - SEC FILING ACTUATE THERAPEUTICS INC - ENTERS AT THE MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY AND CRAIG-HALLUM - SEC FILING Further company coverage: ACTU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsHealth Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing
Brief: Actuate Therapeutics Announces Positive Patient Outcomes From Phase 1 Trial
Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing